| Metric | შპს რკ | შპს ირისე | შპს Linema Pharm |
|---|---|---|---|
| Growth | |||
| Revenue | ₾3.8m₾5.7m | ₾10.0m₾3.6m | ₾3.9m₾2.1m |
| Revenue growth | -34.1% | 180.2% | 88.1% |
| Profitability | |||
| EBITDA | ₾93k₾282k | ₾1.6m₾658k | ₾1.6m₾602k |
| EBITDA margin | 2.4%4.9% | 15.6%18.4% | 40.5%28.9% |
| Net profit | ₾81k₾278k | ₾1.5m₾551k | ₾1.5m₾581k |
| Net margin | 2.1%4.9% | 15.0%15.4% | 38.9%27.9% |
| Balance sheet | |||
| Total assets | ₾657k₾803k | ₾3.1m₾1.2m | ₾6.3m₾4.9m |
| Total equity | ₾548k₾527k | ₾2.2m₾989k | ₾5.6m₾4.3m |
| ROE | 14.8%52.8% | 67.9%55.7% | 27.1%13.6% |